Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In vitro assessment of recombinant, mutant immunoglobulin G anti-D devoid of hemolytic activity for treatment of ongoing hemolytic disease of the fetus and newborn.

Transfusion - 1 Jan 2008

Nielsen Leif K, Green Trine H, Sandlie Inger, Michaelsen Terje E, Dziegiel Morten H

Abstract excerpt

BACKGROUND: A specific treatment for ongoing hemolytic disease of the fetus and newborn (HDFN) due to anti-D would be very attractive. One approach could be administration to the mother of nonhemolytic anti-D, which by crossing the placenta can block the binding of hemolytic maternal anti-D. STUD...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Anti-Idiotypic
Share to Antibody-Dependent Cell Cytotoxicity
Share to Cricetulus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Erythroblastosis, Fetal

Share to Hemolysis

Share to Luminescent Measurements

Share to Respiratory Burst

Share to Rho(D) Immune Globulin

Source

Identifiers

PMID: 17764508
DOI: 10.1111/j.1537-2995.2007.01474.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-17764508-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In vitro assessment of recombinant, mutant immunoglobulin G anti-D devoid of hemolytic activity for treatment of ongoing hemolytic disease of the fetus and newborn.PMID 17764508Read ↗

Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newbornSemantic proximity Read ↗

Anti-D in a mother, hemizygous for the variant RHD*DNB gene, associated with hemolytic disease of the fetus and newborn.Semantic proximity Read ↗

Haemolytic disease of the fetus and newbornSemantic proximity Read ↗

Anti-D prophylaxis: past, present and future.Semantic proximity Read ↗

Intravenous Immunoglobulin (IVIG) as a Replacement for Anti-D Prophylaxis: A Systematic Review and Translational Analysis on the Future of Fetal Rhesus Alloimmunization PreventionSemantic proximity Read ↗

The risk assessment study for hemolytic disease of the fetus and newborn in a University Hospital in Turkey.Semantic proximity Read ↗

Disease severity in subsequent pregnancies with RhD immunization: A nationwide cohortSemantic proximity Read ↗

Development of anti-D in a severe delayed hemolytic transfusion reaction due to DAU3, a partial D variant allele.Semantic proximity Read ↗

DEL RBC transfusion should be avoided in particular blood recipient in East Asia due to allosensitization and ineffectiveness.Semantic proximity Read ↗

Secondary anti-D immunization by Del red blood cells.Semantic proximity Read ↗

Anti-D in pregnant women with the RHD(IVS3+1G>A)-associated DEL phenotype.Semantic proximity Read ↗

RHD-negative red cells may be avoided for patients with ambiguous serologic typing for the RHD antigen.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.